John Mandeli
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 34
- Cancer Immunotherapy and Biomarkers 6
- Cancer Treatment and Pharmacology 5
- HER2/EGFR in Cancer Research 5
- Co-authors
- Jonathan D. Schwartz (3 shared papers)Myron Schwartz (6 shared papers)Max W. Sung (6 shared papers)Deborah Lehrer (5 shared papers)James F. Holland (9 shared papers)Alec Goldenberg (2 shared papers)E. Cohen (1 shared paper)Helen Chen (1 shared paper)
- Journals
- Journal of Clinical Oncology (10 papers)Gynecologic Oncology (5 papers)Clinical Cancer Research (3 papers)Cancer Investigation (3 papers)JNCI Journal of the National Cancer Institute (2 papers)
- Partner nations
- United StatesSpainAustralia
In The Last Decade
John Mandeli
80 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 123
- Hepatology 591
- Oncology 659
- Cancer Research 323
- Immunology 322
- Pathology and Forensic Medicine 269
Countries citing papers authored by John Mandeli
This map shows the geographic impact of John Mandeli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Mandeli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Mandeli more than expected).
Fields of papers citing papers by John Mandeli
This network shows the impact of papers produced by John Mandeli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Mandeli. The network helps show where John Mandeli may publish in the future.
Co-authors
The 25 scholars most cited alongside John Mandeli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 379 | |
| 2 | 2002 | 200 | |
| 3 | 2011 | 113 | |
| 4 | 2018 | 97 | |
| 5 | 2015 | 90 | |
| 6 | 2000 | 82 | |
| 7 | 2001 | 76 | |
| 8 | 1988 | 76 | |
| 9 | 2007 | 61 | |
| 10 | 2014 | 53 | |
| 11 | 2013 | 51 | |
| 12 | 2006 | 48 | |
| 13 | 2014 | 41 | |
| 14 | 1993 | 39 | |
| 15 | 2006 | 39 | |
| 16 | 2016 | 38 | |
| 17 | 2013 | 37 | |
| 18 | 1994 | 37 | |
| 19 | 2004 | 32 | |
| 20 | 1991 | 32 |
About John Mandeli
John Mandeli is a scholar working on Oncology, Molecular Biology, Immunology, Surgery and Pulmonary and Respiratory Medicine, having authored 82 papers that have together received 2.2k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (11 papers), Immunotherapy and Immune Responses (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Multiple Myeloma Research and Treatments (6 papers), Intraperitoneal and Appendiceal Malignancies (6 papers), Cancer Treatment and Pharmacology (5 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Hepatology (591 citations), Oncology (659 citations), Cancer Research (323 citations), Immunology (322 citations) and Pathology and Forensic Medicine (269 citations). John Mandeli has collaborated with scholars based in United States, Spain and Australia. Frequent co-authors include Jonathan D. Schwartz, Myron Schwartz, Max W. Sung, Deborah Lehrer, James F. Holland, Alec Goldenberg, E. Cohen, Helen Chen, Sean Clark-Garvey and E Popa. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, Clinical Cancer Research, Cancer Investigation and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.